DK0558241T3 - Ny cephalosporin C-acylase - Google Patents

Ny cephalosporin C-acylase

Info

Publication number
DK0558241T3
DK0558241T3 DK93301250.2T DK93301250T DK0558241T3 DK 0558241 T3 DK0558241 T3 DK 0558241T3 DK 93301250 T DK93301250 T DK 93301250T DK 0558241 T3 DK0558241 T3 DK 0558241T3
Authority
DK
Denmark
Prior art keywords
acylase
amino acid
ala
native
acid sequence
Prior art date
Application number
DK93301250.2T
Other languages
English (en)
Inventor
Mineo Niwa
Yoshimasa Saito
Hitoshi Sasaki
Yoshinori Ishii
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0558241T3 publication Critical patent/DK0558241T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/02Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK93301250.2T 1992-02-27 1993-02-19 Ny cephalosporin C-acylase DK0558241T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204439A GB9204439D0 (en) 1992-02-27 1992-02-27 A new cephalosporin c acylase

Publications (1)

Publication Number Publication Date
DK0558241T3 true DK0558241T3 (da) 1995-07-03

Family

ID=10711322

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93301250.2T DK0558241T3 (da) 1992-02-27 1993-02-19 Ny cephalosporin C-acylase

Country Status (15)

Country Link
US (1) US5336613A (da)
EP (1) EP0558241B1 (da)
JP (1) JPH0614777A (da)
KR (1) KR100276541B1 (da)
CN (1) CN1062903C (da)
AT (1) ATE121784T1 (da)
CA (1) CA2090571A1 (da)
DE (1) DE69300123T2 (da)
DK (1) DK0558241T3 (da)
ES (1) ES2071527T3 (da)
GB (1) GB9204439D0 (da)
GR (1) GR3015943T3 (da)
HU (1) HU220460B1 (da)
TR (1) TR27016A (da)
TW (1) TW274565B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016435A1 (en) * 1990-04-18 1991-10-31 Gist-Brocades N.V. Mutated beta-lactam acylase genes
NZ247464A (en) * 1992-04-24 1994-12-22 Lilly Co Eli Preparation of 2-amino-acetamidocephalosporin derivatives, the 2-acetamido group substituted in the 2-position by a c5-6 cyclic hydrocarbon or a c5-heterocycle
TW400384B (en) * 1993-11-01 2000-08-01 Fujisawa Pharmaceutical Co A new cephalosporin C acylase
ATE189477T1 (de) * 1994-08-12 2000-02-15 Dsm Nv Mutierte penicillin-g-acylase gene
CN1065278C (zh) * 1994-08-27 2001-05-02 中国科学院上海植物生理研究所 一步两酶法制造7-氨基头孢烷酸
GB9423212D0 (en) * 1994-11-17 1995-01-04 Glaxo Group Ltd Industrial enzymes
US5821049A (en) * 1996-04-05 1998-10-13 Viratest Carcinogen Monitoring, Ltd In vitro assay for identification of carcinogens
US6153429A (en) * 1996-04-05 2000-11-28 Vera Genics Ltd. Cell lines useful for in vitro assay for indentification of carcinogens
HU226348B1 (en) 1996-11-05 2008-09-29 Bristol Myers Squibb Co Mutant penicillin g acylases
KR100530299B1 (ko) * 2003-08-11 2005-11-22 산도즈 게엠베하 변이 세팔로스포린 c 아실라제 및 이를 이용한 7-aca 제조방법
ITMI20040016A1 (it) * 2004-01-12 2004-04-12 Antibiotics S P A Cefalosporina c acilasi
WO2007073947A2 (en) * 2005-12-28 2007-07-05 Dsm Ip Assets B.V. Mutant type ii beta- lactam acylases
CN109913436B (zh) * 2017-12-12 2023-05-23 石药集团圣雪葡萄糖有限责任公司 含有一个或几个点突变的头孢菌素c酰化酶突变体及其制备方法
CN112662655B (zh) * 2020-12-29 2022-05-03 山东金城柯瑞化学有限公司 头孢菌素c酰化酶突变体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPS61152286A (ja) * 1984-12-27 1986-07-10 Asahi Chem Ind Co Ltd セフアロスポリンcアシラ−ゼ産生遺伝情報を担うdna断片
US4752585A (en) * 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
US4835260A (en) * 1987-03-20 1989-05-30 Genetics Institute, Inc. Erythropoietin composition
IL87276A (en) 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
GB9019724D0 (en) * 1990-09-10 1990-10-24 Fujisawa Pharmaceutical Co Cephalosporin c acylase

Also Published As

Publication number Publication date
GB9204439D0 (en) 1992-04-15
ATE121784T1 (de) 1995-05-15
US5336613A (en) 1994-08-09
TW274565B (da) 1996-04-21
JPH0614777A (ja) 1994-01-25
GR3015943T3 (en) 1995-07-31
KR930017918A (ko) 1993-09-20
DE69300123T2 (de) 1996-03-28
HU9300557D0 (en) 1993-05-28
EP0558241A3 (en) 1993-12-01
CN1062903C (zh) 2001-03-07
EP0558241B1 (en) 1995-04-26
TR27016A (tr) 1994-09-15
CN1085252A (zh) 1994-04-13
HUT65664A (en) 1994-07-28
DE69300123D1 (de) 1995-06-01
CA2090571A1 (en) 1993-08-28
EP0558241A2 (en) 1993-09-01
HU220460B1 (hu) 2002-02-28
ES2071527T3 (es) 1995-06-16
KR100276541B1 (ko) 2000-12-15

Similar Documents

Publication Publication Date Title
DK0558241T3 (da) Ny cephalosporin C-acylase
DE3478469D1 (en) Maltogenic amylase enzyme product, preparation and use thereof
AU1623792A (en) Nonaqueous liquid automatic dishwashing composition containing enzymes
GB9215834D0 (en) Cell culture
ES2084117T3 (es) Cefalosporina c acilasa.
IE810114L (en) N-benzyloxycarbonyl-l-aspartic acid
ITRM920809A1 (it) Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
IE801762L (en) Insulin-zinc crystals
JPS57171925A (en) Antibiotic compound
ES8606887A1 (es) Un metodo para la produccion microbica de interferon.
CA2172954A1 (en) Enzyme and its use in preparing (s)-pipecolic acid
ES8308832A1 (es) Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina.
CA2133345A1 (en) A Method of Limiting the Survival of Genetically Engineered Microorganisms in Their Environment
JPS6474986A (en) Protease and a novel microorganism producing the same
Stabnikova et al. Self-breeding of neuston forms of bacteria.
Britsyna et al. Stability of proteinases immobilized on siliceous supports by the glutaraldehyde and benzoquinone methods.
TW243453B (en) Cloning and characterization of a cardiac adenylyl cyclase
JPS6471476A (en) Microbial strain capable of producing l-amino acid
JPS5586A (en) Preparation of d-n-carbamyl(p-hydroxyphenyl)glycine
KR880004098A (ko) β-락탐의 효소적 제조방법
MD845G2 (ro) Metodă de determinare a activităţii enzimelor lipolitice în obiecte microbiologice
JPS5729288A (en) Preparation of d - -beta-hydroxyisobutyric acid